media article: Initial Trials on New Ovarian Cancer Tests (blood) Exhibit Extremely High Accuracy

Blogger's Note:
media reporting issues = watch the word 'extremely' (94 patients in study); comment on symptoms/early stage;

also note the research comment regarding lack of access to ovarian cancer patients/study ?? (needs 500 pts)

 ..........................................................................................................................
“The caveat is we don’t currently have 500 patients with the same type of ovarian cancer, so we’re going to look at other types of ovarian cancer,” said Fernandez. “It’s possible that there are also signatures for other cancers, not just ovarian, so we’re also going to be using the same approach to look at other types of cancers. We’ll be working with collaborators in Atlanta and elsewhere.”

comments in the media item:
In addition to having a relatively low prevalence ovarian cancer is also asymptomatic in the early stages. Therefore, if further testing confirms the ability to accurately detect ovarian cancer by analyzing metabolites in the serum of women, doctors will be able detect the disease early and save many lives.